2417089-06-4
Chemical Structure
(S)-DOTAGA.(SA.FAPi)2
- CAS No.: 2417089-06-4
- Formula:C71H83F4N17O17
- Molecular Weight:1522.52
InChIKey: QLZYFSGYVUKTPF-RCVAIWALSA-N
SMILES: N#C[C@@H]1CC(F)(CN1C(CNC(C2=CC=NC3=C2C=C(C=C3)OCCCCNC4=C(C(C4=O)=O)NCCNC(CC[C@H](N5CCN(CCN(CCN(CC5)CC(O)=O)CCNC6=C(C(C6=O)=O)NCCCCOC7=CC8=C(N=CC=C8C(NCC(N9CC(F)(C[C@H]9C#N)F)=O)=O)C=C7)CC(O)=O)C(O)=O)=O)=O)=O)F
Biological Activity: (S)-DOTAGA.(SA.FAPi)2 is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs). RDCs have the capability to specifically target biomolecules and can be used in medical imaging[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(S)-DOTAGA.(SA.FAPi)2 | (S)-DOTAGA.(SA.FAPi)2 is a precursor for radiopharmaceutical labeling, which can be combined with radionuclides to create radionuclide drug conjugates (RDCs). RDCs have the capability to specifically target biomolecules and can be used in medical imaging. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
